Loading...
XASX
IME
Market cap10mUSD
Jul 10, Last price  
0.29AUD
1Q
-28.75%
IPO
-100.00%
Name

ImExHS Ltd

Chart & Performance

D1W1MN
XASX:IME chart
P/E
—
P/S
0.54
EPS
—
Div Yield, %
—
Shrs. gr., 5y
15.55%
Rev. gr., 5y
21.56%
Revenues
29m
+9.04%
18,169,0006,374,0005,065,00012,028,0000000091,02080,1173,546,0005,780,0007,736,00010,914,00013,373,00017,117,00019,669,00026,569,00028,970,057
Net income
-3m
L+9.80%
-13,898,000-29,499,000-1,996,000-24,933,000-344,552691,239-492,610-190,266-121,905-2,849,304-4,491,00068,469-4,887,000-6,002,000-3,616,000-4,700,000-3,039,000-4,192,000-2,625,000-2,882,313
CFO
565k
P
-11,646,000-10,885,000-2,238,000-2,657,513-84,503-1,160,658-584,700-167,968-129,344-1,006,279-3,651,460-109,862-1,541,439-4,089,807-1,467,042-2,968,041-2,198,7382,609,641-634,679564,707

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

ImExHS Limited delivers cloud-powered medical imaging technologies to customers worldwide, including those in Australia. The firm specializes in the development and sale of modular imaging software systems, which encompass comprehensive information management platforms for disciplines such as radiology, cardiology, and pathology, alongside a robust picture archiving and communication system (PACS). Its principal software solutions include AQUILA for radiology, ALULA for pathology, and Antero for cardiology. Moreover, ImExHS offers STELLA.I, a suite of artificial intelligence tools hosted in the cloud, crafted to bolster diagnostic capabilities for medical professionals. The company further extends outsourced radiology and teleradiology services to hospitals and various other healthcare entities. Established in 2001, ImExHS Limited operates from its base in Mascot, Australia.
URL
http://omnimarkettide.com/
IPO date
Dec 14, 2005
Employees
300
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT